Cargando…

Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data

PURPOSE: Early detection of microvascular changes in the retina may be important for the risk assessment of cardiovascular health. Therefore, the purpose of this study was to investigate imaging biomarkers in fluorescein angiography (FA) as potential predictors for cardiovascular mortality. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldbach, Felix, Mylonas, Georgios, Riegelnegg, Martin, Brugger, Jonas, Schmidt-Erfurth, Ursula, Gerendas, Bianca S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071156/
https://www.ncbi.nlm.nih.gov/pubmed/35511907
http://dx.doi.org/10.1371/journal.pone.0266423
_version_ 1784700790610329600
author Goldbach, Felix
Mylonas, Georgios
Riegelnegg, Martin
Brugger, Jonas
Schmidt-Erfurth, Ursula
Gerendas, Bianca S.
author_facet Goldbach, Felix
Mylonas, Georgios
Riegelnegg, Martin
Brugger, Jonas
Schmidt-Erfurth, Ursula
Gerendas, Bianca S.
author_sort Goldbach, Felix
collection PubMed
description PURPOSE: Early detection of microvascular changes in the retina may be important for the risk assessment of cardiovascular health. Therefore, the purpose of this study was to investigate imaging biomarkers in fluorescein angiography (FA) as potential predictors for cardiovascular mortality. METHODS: In this retrospective, matched case-control study, we included FA images from clinical routine data between 2007 and 2018 of 100 patients who died of macrovascular events (Group 1) and 100 age- and sex-matched controls (Group 2). All patients were under treatment for different, mostly retinal, ocular diseases. FA images were used for the measurement of the foveal avascular zone (FAZ) and the arteriolar and venular caliber. RESULTS: Patients mean age on examination day was 69.5 ± 8.3 years with a 1:1 female:male subject ratio. Mean FAZ area of our sample was 0.340 ± 0.135 mm(2) for Group 1 and 0.264 ± 0.137 mm(2) for Group 2 (P < 0.001), showing a larger FAZ area in patients who subsequently died of macrovascular-related systemic diseases. CONCLUSIONS: Individuals effected by a macrovascular-related disease show a larger FAZ on FA examinations before the event compared to patients which are unaffected. Our results highlight a possible role of the FAZ as additional biomarker for the cardiovascular condition.
format Online
Article
Text
id pubmed-9071156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90711562022-05-06 Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data Goldbach, Felix Mylonas, Georgios Riegelnegg, Martin Brugger, Jonas Schmidt-Erfurth, Ursula Gerendas, Bianca S. PLoS One Research Article PURPOSE: Early detection of microvascular changes in the retina may be important for the risk assessment of cardiovascular health. Therefore, the purpose of this study was to investigate imaging biomarkers in fluorescein angiography (FA) as potential predictors for cardiovascular mortality. METHODS: In this retrospective, matched case-control study, we included FA images from clinical routine data between 2007 and 2018 of 100 patients who died of macrovascular events (Group 1) and 100 age- and sex-matched controls (Group 2). All patients were under treatment for different, mostly retinal, ocular diseases. FA images were used for the measurement of the foveal avascular zone (FAZ) and the arteriolar and venular caliber. RESULTS: Patients mean age on examination day was 69.5 ± 8.3 years with a 1:1 female:male subject ratio. Mean FAZ area of our sample was 0.340 ± 0.135 mm(2) for Group 1 and 0.264 ± 0.137 mm(2) for Group 2 (P < 0.001), showing a larger FAZ area in patients who subsequently died of macrovascular-related systemic diseases. CONCLUSIONS: Individuals effected by a macrovascular-related disease show a larger FAZ on FA examinations before the event compared to patients which are unaffected. Our results highlight a possible role of the FAZ as additional biomarker for the cardiovascular condition. Public Library of Science 2022-05-05 /pmc/articles/PMC9071156/ /pubmed/35511907 http://dx.doi.org/10.1371/journal.pone.0266423 Text en © 2022 Goldbach et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Goldbach, Felix
Mylonas, Georgios
Riegelnegg, Martin
Brugger, Jonas
Schmidt-Erfurth, Ursula
Gerendas, Bianca S.
Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
title Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
title_full Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
title_fullStr Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
title_full_unstemmed Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
title_short Association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
title_sort association of microvascular biomarkers in fluorescein angiography with macrovascular-related mortality in clinical routine data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071156/
https://www.ncbi.nlm.nih.gov/pubmed/35511907
http://dx.doi.org/10.1371/journal.pone.0266423
work_keys_str_mv AT goldbachfelix associationofmicrovascularbiomarkersinfluoresceinangiographywithmacrovascularrelatedmortalityinclinicalroutinedata
AT mylonasgeorgios associationofmicrovascularbiomarkersinfluoresceinangiographywithmacrovascularrelatedmortalityinclinicalroutinedata
AT riegelneggmartin associationofmicrovascularbiomarkersinfluoresceinangiographywithmacrovascularrelatedmortalityinclinicalroutinedata
AT bruggerjonas associationofmicrovascularbiomarkersinfluoresceinangiographywithmacrovascularrelatedmortalityinclinicalroutinedata
AT schmidterfurthursula associationofmicrovascularbiomarkersinfluoresceinangiographywithmacrovascularrelatedmortalityinclinicalroutinedata
AT gerendasbiancas associationofmicrovascularbiomarkersinfluoresceinangiographywithmacrovascularrelatedmortalityinclinicalroutinedata